This Article  • Full text  • PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (125)  • Contact me when this article is cited  Related Content  • Related article  • Similar articles in this journal  Topic Collections  • Aging/ Geriatrics  • Alzheimer Disease  • Dementias  • Alert me on articles by topic  Social Bookmarking   What's this?

Vahram Haroutunian, PhD; Daniel P. Perl, MD; Dushyant P. Purohit, MD; Deborah Marin, MD; Khalid Khan, MD; Melinda Lantz, MD; Kenneth L. Davis, MD; Richard C. Mohs, PhD

Arch Neurol. 1998;55:1185-1191.

Background  Identification of the neuropathological lesions that are most closely associated with the earliest symptoms of Alzheimer disease (AD) is crucial to the understanding of the disease process and the development of treatment strategies to affect its progress. Do the classical neuropathological lesions of AD precede, follow, or occur in synchrony with the earliest signs of cognitive deterioration?

Design and Outcome Measures  We examined the extent of neuritic plaque (NP) formation in 5 neocortical regions and the hippocampus, entorhinal cortex, and amygdala in 66 elderly subjects with no dementia, questionable dementia, or mild dementia as assessed using the Clinical Dementia Rating Scale (CDR).

Setting and Patients  Postmortem study of nursing home residents.

Results  Even questionable dementia (CDR, 0.5) was associated with a significant (P=.04) increase in neocortical NP density. The density of NPs increased further with increasing dementia severity in all brain regions examined. However, subjects with questionable dementia or definite but mild dementia did not differ significantly from each other. Density of NPs was nearly maximal in subjects with moderate dementia (CDR=2.0), suggesting that other neuropathological changes may be responsible for cognitive deficits beyond this level. Dementia severity correlated significantly with the density of NPs in all brain regions examined (r range, 0.47-0.56; P <.001), even when subjects with a CDR of 0 were excluded.

Conclusions  These findings are consistent with the hypothesis that NPs are among the earliest neuropathological lesions in AD. Even very mild or questionable dementia is associated with increased density of neocortical NPs that do not distinguish between clinically questionable vs definite dementia.

From the the Departments of Psychiatry (Drs Haroutunian, Marin, Khan, Davis, and Mohs) and Pathology (Drs Perl and Purohit), The Mount Sinai School of Medicine, New York, NY; Psychiatry Service, Bronx Veterans Affairs Medical Center, Bronx, NY (Drs Perl and Purohit); and Jewish Home and Hospital for Aged, Manhattan, NY (Dr Lantz).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?

RELATED ARTICLE

New Neuropathological Criteria for Alzheimer Disease
Bradley T. Hyman
Arch Neurol. 1998;55(9):1174-1176.
EXTRACT | FULL TEXT  

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Linking Hippocampal Structure and Function to Memory Performance in an Aging Population
Reitz et al.
Arch Neurol 2009;66:1385-1392.
ABSTRACT | FULL TEXT  

Validity of the Severe Impairment Battery Short Version
de Jonghe et al.
J. Neurol. Neurosurg. Psychiatry 2009;80:954-959.
ABSTRACT | FULL TEXT  

Less Alzheimer disease neuropathology in medicated hypertensive than nonhypertensive persons
Hoffman et al.
Neurology 2009;72:1720-1726.
ABSTRACT | FULL TEXT  

The P2X7 Receptor Drives Microglial Activation and Proliferation: A Trophic Role for P2X7R Pore
Monif et al.
J. Neurosci. 2009;29:3781-3791.
ABSTRACT | FULL TEXT  

PGC-1{alpha} Expression Decreases in the Alzheimer Disease Brain as a Function of Dementia
Qin et al.
Arch Neurol 2009;66:352-361.
ABSTRACT | FULL TEXT  

Frequent Amyloid Deposition Without Significant Cognitive Impairment Among the Elderly
Aizenstein et al.
Arch Neurol 2008;65:1509-1517.
ABSTRACT | FULL TEXT  

Insulin in combination with other diabetes medication is associated with less Alzheimer neuropathology
Beeri et al.
Neurology 2008;71:750-757.
ABSTRACT | FULL TEXT  

Role of the Neuropathology of Alzheimer Disease in Dementia in the Oldest-Old
Haroutunian et al.
Arch Neurol 2008;65:1211-1217.
ABSTRACT | FULL TEXT  

Chromosome 17 and 21 aneuploidy in buccal cells is increased with ageing and in Alzheimer's disease
Thomas and Fenech
Mutagenesis 2008;23:57-65.
ABSTRACT | FULL TEXT  

Amyloid Deposition Begins in the Striatum of Presenilin-1 Mutation Carriers from Two Unrelated Pedigrees
Klunk et al.
J. Neurosci. 2007;27:6174-6184.
ABSTRACT | FULL TEXT  

Synaptic alterations in CA1 in mild Alzheimer disease and mild cognitive impairment
Scheff et al.
Neurology 2007;68:1501-1508.
ABSTRACT | FULL TEXT  

Auditory cortical activity in amnestic mild cognitive impairment: relationship to subtype and conversion to dementia
Golob et al.
Brain 2007;130:740-752.
ABSTRACT | FULL TEXT  

Body mass index in older persons is associated with Alzheimer disease pathology
Buchman et al.
Neurology 2006;67:1949-1954.
ABSTRACT | FULL TEXT  

Quantitative MR Imaging in Alzheimer Disease
Ramani et al.
Radiology 2006;241:26-44.
ABSTRACT | FULL TEXT  

Elevated cortical zinc in Alzheimer disease.
Religa et al.
Neurology 2006;67:69-75.
ABSTRACT | FULL TEXT  

Coronary artery disease is associated with Alzheimer disease neuropathology in APOE4 carriers
Beeri et al.
Neurology 2006;66:1399-1404.
ABSTRACT | FULL TEXT  

Neuropathologic outcome of mild cognitive impairment following progression to clinical dementia.
Jicha et al.
Arch Neurol 2006;63:674-681.
ABSTRACT | FULL TEXT  

Conversion of Mild Cognitive Impairment to Alzheimer Disease Predicted by Hippocampal Atrophy Maps
Apostolova et al.
Arch Neurol 2006;63:693-699.
ABSTRACT | FULL TEXT  

Dissociation of neuropathology from severity of dementia in late-onset Alzheimer disease
Prohovnik et al.
Neurology 2006;66:49-55.
ABSTRACT | FULL TEXT  

Mild Cognitive Impairment Is Early-Stage Alzheimer Disease: Time to Revise Diagnostic Criteria
Morris
Arch Neurol 2006;63:15-16.
FULL TEXT  

Antecedent Biomarkers of Alzheimer's Disease: The Adult Children Study
Coats and Morris
J Geriatr Psychiatry Neurol 2005;18:242-244.
ABSTRACT  

Type 2 Diabetes Is Negatively Associated With Alzheimer's Disease Neuropathology
Beeri et al.
Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2005;60:471-475.
ABSTRACT | FULL TEXT  

The importance of neuritic plaques and tangles to the development and evolution of AD
Tiraboschi et al.
Neurology 2004;62:1984-1989.
ABSTRACT | FULL TEXT  

Higher atrophy rate of entorhinal cortex than hippocampus in AD
Du et al.
Neurology 2004;62:422-427.
ABSTRACT | FULL TEXT  

Influence of Alzheimer pathology on clinical diagnostic accuracy in dementia with Lewy bodies
Merdes et al.
Neurology 2003;60:1586-1590.
ABSTRACT | FULL TEXT  

Amyloid {beta} Pathology in Alzheimer's Disease and Schizophrenia
Religa et al.
Am. J. Psychiatry 2003;160:867-872.
ABSTRACT | FULL TEXT  

Caspase Gene Expression in the Brain as a Function of the Clinical Progression of Alzheimer Disease
Pompl et al.
Arch Neurol 2003;60:369-376.
ABSTRACT | FULL TEXT  

Cognitive decline in AD and mild cognitive impairment is associated with global brain damage
van der Flier et al.
Neurology 2002;59:874-879.
ABSTRACT | FULL TEXT  

Correlation Between A{beta}x-40-, A{beta}x-42-, and A{beta}x-43-Containing Amyloid Plaques and Cognitive Decline
Parvathy et al.
Arch Neurol 2001;58:2025-2031.
ABSTRACT | FULL TEXT  

Magnetic resonance imaging of the entorhinal cortex and hippocampus in mild cognitive impairment and Alzheimer's disease
Du et al.
J. Neurol. Neurosurg. Psychiatry 2001;71:441-447.
ABSTRACT | FULL TEXT  

Neuron Number in the Entorhinal Cortex and CA1 in Preclinical Alzheimer Disease
Price et al.
Arch Neurol 2001;58:1395-1402.
ABSTRACT | FULL TEXT  

Attentional control in Alzheimer's disease
Baddeley et al.
Brain 2001;124:1492-1508.
ABSTRACT | FULL TEXT  

Neuronal Cyclooxygenase 2 Expression in the Hippocampal Formation as a Function of the Clinical Progression of Alzheimer Disease
Ho et al.
Arch Neurol 2001;58:487-492.
ABSTRACT | FULL TEXT  

Absence of cognitive impairment or decline in preclinical Alzheimer's disease
Goldman et al.
Neurology 2001;56:361-367.
ABSTRACT | FULL TEXT  

The decline in synapses and cholinergic activity is asynchronous in Alzheimer's disease
Tiraboschi et al.
Neurology 2000;55:1278-1283.
ABSTRACT | FULL TEXT  

Impact of emotion on memory: Controlled study of the influence of emotionally charged material on declarative memory in Alzheimer's disease
KAZUI et al.
Br. J. Psychiatry 2000;177:343-347.
ABSTRACT | FULL TEXT  

""Preclinical"" AD revisited: Neuropathology of cognitively normal older adults
Schmitt et al.
Neurology 2000;55:370-376.
ABSTRACT | FULL TEXT  

Ibuprofen Suppresses Plaque Pathology and Inflammation in a Mouse Model for Alzheimer's Disease
Lim et al.
J. Neurosci. 2000;20:5709-5714.
ABSTRACT | FULL TEXT  

Contribution of Lewy Body Inclusions to Dementia in Patients With and Without Alzheimer Disease Neuropathological Conditions
Haroutunian et al.
Arch Neurol 2000;57:1145-1150.
ABSTRACT | FULL TEXT  

Cytokine Gene Expression as a Function of the Clinical Progression of Alzheimer Disease Dementia
Luterman et al.
Arch Neurol 2000;57:1153-1160.
ABSTRACT | FULL TEXT  

Correlation Between Elevated Levels of Amyloid {beta}-Peptide in the Brain and Cognitive Decline
Naslund et al.
JAMA 2000;283:1571-1577.
ABSTRACT | FULL TEXT  

The Origins of Alzheimer Disease: A Is for Amyloid
Selkoe
JAMA 2000;283:1615-1617.
FULL TEXT  

The Oregon Brain Aging Study: Neuropathology accompanying healthy aging in the oldest old
Green et al.
Neurology 2000;54:105-105.
ABSTRACT | FULL TEXT  

Neuropeptide Abnormalities in Patients With Early Alzheimer Disease
Davis et al.
Arch Gen Psychiatry 1999;56:981-987.
ABSTRACT | FULL TEXT  

Neuropathology in older people with disequilibrium of unknown cause
Whitman et al.
Neurology 1999;53:375-375.
ABSTRACT | FULL TEXT  

Neurofibrillary Tangles in Nondemented Elderly Subjects and Mild Alzheimer Disease
Haroutunian et al.
Arch Neurol 1999;56:713-718.
ABSTRACT | FULL TEXT  

Cholinergic Markers in Elderly Patients With Early Signs of Alzheimer Disease
Davis et al.
JAMA 1999;281:1401-1406.
ABSTRACT | FULL TEXT  

New Neuropathological Criteria for Alzheimer Disease
Hyman
Arch Neurol 1998;55:1174-1176.
FULL TEXT